Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms - Top-Institutions - MDSpire

Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms

  • By

  • Elisabeth Brandstetter Figueroa

  • Anne E P Frosch

  • Kristina S Burrack

  • Gayathri Dileepan

  • Rachael Goldsmith

  • Morgan Harris

  • Nwando Ikeogu

  • Hodan Jibrell

  • Sangeitha Thayalan

  • Robin L Dewar

  • Chetan Shenoy

  • Irini Sereti

  • Jason V Baker

  • January 30, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health (NIH) - RECOVER Initiative
    National Institutes of Health (NIH) - RECOVER Initiative

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Epidemiology
    • Post-Acute COVID-19 Research

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Pulmonology
    • Neurology
    • Epidemiology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Neurology
    • Clinical Research

  • #4

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Pulmonology
    • Immunology
    • Clinical Epidemiology

  • #5

    University of Washington School of Medicine
    University of Washington School of Medicine

    Seattle, WA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Virology
    • Clinical Research

Original Source(s)

Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms

  • by Elisabeth Brandstetter Figueroa, Anne E P Frosch, Kristina S Burrack, Gayathri Dileepan, Rachael Goldsmith, Morgan Harris, Nwando Ikeogu, Hodan Jibrell, Sangeitha Thayalan, Robin L Dewar, Chetan Shenoy, Irini Sereti, Jason V Baker

  • January 30, 2025

Related Content

Impact of COVID-19 history on the prevalence of coronary slow flow: a comparative study in unstable angina patients

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing

Recent COVID-19 Shot Linked to Less Spread

Protection against spread appeared strongest within 6 months of vaccination, while exposed vaccinated contacts showed no measurable reduction in infection risk.